Research

Dr. Arun Sridhar leads the JACC Scientific Statement on Consumer Wearables in Cardiac Care

AI-driven algorithm predicts risk of PCI complications.

Elevated levels of Lipoprotein(a) — also known as Lp(a) — can increase your risk for heart attack. About one in five people inherit high Lp(a), which can’t be controlled with lifestyle changes, but a clinical trial is testing an investigational drug that may help lower Lp(a).

There are many reasons to participate in clinical trials, from gaining access to new treatments to advancing care for future generations. Another reason? Getting screened for a study might just uncover a condition you never knew you had.

Jon Clifton, RN, CHPN, Inland Northwest Heart Failure Center of Excellence, authored a white paper detailing the collaborative effort between Pulse Heart Institute and DispatchHealth to address the treatment of congestive heart failure and reduce 30-day hospital readmissions. Together, Pulse and DispatchHealth were able to reduce readmission rates significantly.

A MultiCare physician is leading efforts to prevent the premature deaths of police officers, firefighters, airline pilots and soldiers, along with others in high-risk jobs.